Merck & Co/MSD has agreed to buy Pandion for ... and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate LY3471851 ...
Pharmaceutical company Eli Lilly (LLY) has been raking it in lately ... Thus it, along with Merck (MRK), got together to create the Young Institute Pharmaceutical Manufacturing Consortium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback